Affy, Illumina Arrays Remain Platforms of Choice for Consumer Genomics Firms

Most DTC genomic service providers use either custom or catalog chips made by the two West Coast vendors, though some vow to integrate next-gen sequencing into their services when cost and reliability issues improve.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.